Trial Profile
Clinical Trials Insight: 700028323
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Jul 2019
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Sponsors Adhera Therapeutics
- 11 Nov 2007 New trial record.